Physician profile
Keyur A Chavda
NPI 1124218128
$8,451.33
in general payments reported to CMS, 2019-2025
43 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,067 · 2020: $214 · 2021: $564 · 2022: $608 · 2023: $1,425 · 2024: $901 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,800 · Consulting Fee: $700 · Travel and Lodging: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.64 |
| Consulting Fee | $700.00 |
| Travel and Lodging | $498.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,807.21 | 2019-2025 | Da Vinci Surgical System |
| Kerecis Limited | $823.98 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $801.41 | 2021-2025 | Endoflip, Intellis Adaptivestim, Endurant Iis |
| Tela Bio, INC. | $504.41 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Standard Bariatrics, INC. | $298.92 | 2021-2022 | |
| Smith+Nephew, INC. | $233.60 | 2020-2022 | |
| Keswick Pharmaceuticals LLC | $180.84 | 2019 | |
| Novo Nordisk INC | $161.29 | 2021-2025 | Wegovy |
| W. L. Gore & Associates, INC. | $148.59 | 2021-2022 | |
| Integra Lifesciences Corporation | $124.26 | 2021-2023 | Integra, Surgimend, Omnigraft |
| Convatec INC. | $108.06 | 2023-2024 | |
| Access Pro Medical, LLC | $107.43 | 2023 | Matriderm |
| Conmed Corporation | $88.89 | 2021 | |
| Paratek Pharmaceuticals, INC. | $74.73 | 2019-2021 | |
| Organogenesis INC. | $73.69 | 2021-2025 | Puraply, Apligraf |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $71.13 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Eluvia |
| Medtronic Vascular, INC. | $67.27 | 2019 | |
| Biocomposites INC | $66.33 | 2019 | |
| Daiichi Sankyo INC. | $62.36 | 2019-2020 | |
| Cook Medical LLC | $58.60 | 2020 | |
| Bioventus LLC | $54.14 | 2022-2023 | |
| Ethicon US, LLC | $51.89 | 2022-2025 | Echelon Flex |
| Amniox Medical, INC. | $46.60 | 2019 | |
| Teleflex LLC | $43.32 | 2023-2025 | Deknatel, Titan Sgs Standard Gastric Stapler |
| Kci USA, INC. | $42.89 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $32.12 | 2019-2021 | |
| Bolder Surgical LLC | $27.08 | 2019-2021 | |
| Hologic Sales and Service, LLC | $25.44 | 2024 | Coolseal Generator |
| Shockwave Medical, INC | $23.04 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $22.61 | 2020 | |
| Reprise Biomedical, INC. | $22.58 | 2023 | Miro3d |
| Angiodynamics, INC. | $20.63 | 2024 | Venacure 1470 Pro |
| Eagle Pharmaceuticals, INC. | $19.98 | 2023 | |
| Acera Surgical, INC. | $19.98 | 2024 | Restrata Wound Matrix |
| Innocoll Pharmaceuticals Limited | $19.37 | 2022 | |
| Aroa Biosurgery Incorporated | $18.76 | 2023 | |
| Davol INC. | $16.99 | 2025 | Arista |
| Lucid Diagnostics INC. | $16.55 | 2023 | |
| Heron Therapeutics, INC. | $15.08 | 2023 | Aponvie |
| Solventum Corporation | $14.60 | 2025 | Activ.A.C. |
| Trevena, INC. | $14.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.20 | 2021 | |
| Lexington Medical, INC. | $8.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyur Chavda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.